Thanks @vrs37, I meant OSL (although similar complaints could be levelled at RAP). Apologies to the forum for the error.
I agree with your comments. For me, the next few months will be a watershed. If the sales don’t come and reimbursements finalised I cant see how the MD will salvage any credibility with the market.
I hold a number of stocks for which this quarter holds out the promise of significant catalysts but I think OSL are facing the toughest test.
GLTAH
OSL Chart, page-76
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $30.58M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 1.0¢ | 0.9¢ | $191.9K | 21.25M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 8525000 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 964494 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| OSL (ASX) Chart |